| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/12/2008 | WO2007115931A8 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors |
| 06/12/2008 | WO2007089548A3 Compounds and methods for modulating protein trafficking |
| 06/12/2008 | WO2007087370A3 Tat-038 and methods of assessing and treating cancer |
| 06/12/2008 | WO2007068895A9 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139666 Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues |
| 06/12/2008 | US20080139640 Hydroxamates, Their Manufacture And Use As Pharmaceutical Agents |
| 06/12/2008 | US20080139637 Reacting an alpha,beta-unsaturated compound and indole or indole derivative with a lewis acid catalyst; industrial scale synthesis of 1,1,3-tris(indol-3-yl)cyclohexane for example; treating cancer cells with the mutation of the p53 tumor suppressor gene |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139633 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/12/2008 | US20080139632 Such as 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-2-hydroxybenzoic acid for modulating premature translation termination or nonsense-mediated mRNA decay in cells |
| 06/12/2008 | US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 06/12/2008 | US20080139629 Administering an organic arsenical compound such as S-dipropylarsinyl-1-thioglycerol; anticancer, antitumor, psoriasis, retinopathy, arthritis |
| 06/12/2008 | US20080139622 Decahydronaphthalene Compounds |
| 06/12/2008 | US20080139620 Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's |
| 06/12/2008 | US20080139611 Use of [2-(7-Trifluoromethyl-quinolin-4-ylamino)-phenyl]-acetic acid or esters or salts thereof for example; pain, fever, or inflammation, a proliferative disorder, skin disorders, eye disorders; compound disclosed in US patent 3,637,710 |
| 06/12/2008 | US20080139607 Inhibitors of the serine protease PAI-1 (plasminogen activator inhibitor type 1); (3R)-8-(3,4-Difluoro-phenyl)-7-heptyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid for example; desulfurization to form corresponding 1-(1-carboxyethyl)-1,2-dihydro-2-oxopyridine compound; coadministering |
| 06/12/2008 | US20080139606 Substituted Pyrrolopyridines, Compositions Containing Them, Manufacturing Process Therefor and Use Thereof |
| 06/12/2008 | US20080139601 3-Cyano-Quinoline Derivatives With Antiproliferative Activity |
| 06/12/2008 | US20080139590 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 06/12/2008 | US20080139587 Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof |
| 06/12/2008 | US20080139586 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction |
| 06/12/2008 | US20080139585 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian |
| 06/12/2008 | US20080139582 Inhibitors of bruton's tyrosine kinase |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139571 Imidazopyrazines as protein kinase inhibitors |
| 06/12/2008 | US20080139570 e.g. N-[2-(6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-3-oxo-4-hydropyridino[2,3-b]pyrazin-4-yl)ethyl]acetamide; antidiabetic agent; abnormal lipid levels, cardiovascular disease, obesity, oily skin conditions, metabolic syndrome |
| 06/12/2008 | US20080139561 e.g. 6-(5-Cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoro-2-(1-(4-fluorophenyl)ethylamino) nicotinonitrile; tropomyosin-related kinases (Trk's) inhibitor; anticarcinogenic agent; hormone related cancer, leukemia; antiinflammatory agent; arthritis, restenosis; autoimmune diseases |
| 06/12/2008 | US20080139557 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |
| 06/12/2008 | US20080139535 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype; |
| 06/12/2008 | US20080139530 7-Aryl 1,5-Dihydro-4,1-Benzoxazepin-2(3H)-One Derivatives And Their Use As Progesterone Receptor Modulators |
| 06/12/2008 | US20080139509 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs |
| 06/12/2008 | US20080139496 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections |
| 06/12/2008 | US20080139490 Rate of dissolution; ease of handling; storage stability; release profile; powder X-ray diffraction pattern peaks at 6.4, 9.9 and 13.2 degrees 2 theta +-0.2 degrees 2 theta; infrared spectrum peaks at 3544, 1732, and 1009 cm-1 |
| 06/12/2008 | US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties |
| 06/12/2008 | US20080139480 Imatinib resistant leukemia; synergistic treatment with such as ciclopirox |
| 06/12/2008 | US20080139479 Intelligent drug carrier capable of selective delivery; reduced side effects; isolated, labeled peptide of amino acid sequence 7; antibodies; kits |
| 06/12/2008 | US20080139475 Inhibition of atf2 activity to treat cancer |
| 06/12/2008 | US20080139471 Compositions and methods to prevent cancer with cupredoxins |
| 06/12/2008 | US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds |
| 06/12/2008 | US20080139460 Binding agents for CD44 glycoproteins and methods of use |
| 06/12/2008 | US20080139457 Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors |
| 06/12/2008 | US20080138445 Pharmaceutical mixture for Hepatitis treatment and its preparation method |
| 06/12/2008 | US20080138437 Reduce toxicity while maintaining efficacy; mix with particulate hydroxyapatite as an auxiliary agent; alkylating agent, antimetabolite, an antitumor antibiotic, plant preparation, hormone preparation, immunotherapeutic agent, cisplatin; injection, infusion, oral administration |
| 06/12/2008 | US20080138431 Microparticle; poly-lactide biodegradable polymer; polyuridylic acid immunogenic single-stranded ribonucleic acid; recombinant Protective Antigen of Bacillus anthracis biologically active macromolecule; cationic polymer or cationic lipid stabilizing agent; mucosal administration via inhaler; parenteral |
| 06/12/2008 | US20080138426 Remedies for sex hormone dependent disease |
| 06/12/2008 | US20080138400 Curcumin analog or metabolite microencapsulated by a polyethylene glycolated liposome of dimyristoyl phosphatidylcholine, cholesterol, and dimyristoyl phsphatidylethanolamine; anticarcinogenic and antiproliferative agents; parenteral colloidal drug delivery system providing improved bioavailability |
| 06/12/2008 | US20080138395 Reduced glutathione or certain thiol derivatives of glutathione in combination with anthocyans or anthocyanidins |
| 06/12/2008 | US20080138379 Preventing birth defects; administering formulation to women from preconception through first trimester of pregnancy |
| 06/12/2008 | US20080138364 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 06/12/2008 | US20080138360 A combined vaccine with immunization schedules that combine prime doses with DNA vaccine and booster doses either with proteins or recombinant viral vectors; chronic hepatitis C, cirrhosis and liver cancer |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138341 Anti-CD70 antibody and its use for the treatment of cancer and immune disorders |
| 06/12/2008 | US20080138338 Polypeptide variants |
| 06/12/2008 | US20080138337 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138329 Inhibitors of Dna Methylation in Tumor Cells |
| 06/12/2008 | US20080138326 Administering reduced coenzyme Q; cosmeceuticals, cosmetics, foods |
| 06/12/2008 | US20080138322 Pretreating with lipophilic substituted saccharide |
| 06/12/2008 | US20080138295 Administering cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide; side effect reduction from chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy; anticarcinogenic and antimetastasis agents; autoimmune diseases |
| 06/12/2008 | US20080138291 e.g. (4-Sulfamoylphenyl)thioureido fluorescein; bind to the enzyme under hypoxic conditions and are able to reverse the tumor acidification mediated by the enzyme; fluorescent dye for tumor detection by positron-emission tomography; antitumor, antiproliferative agent |
| 06/12/2008 | US20080138288 Combinations for treatment of neovasculature |
| 06/12/2008 | US20080138284 Novel Peptides That Promote Lipid Efflux |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/12/2008 | US20080138278 Conjugates of rgd peptides and porphyrin or (bacterio) chlorohyll photosynthesizers and their uses |
| 06/12/2008 | US20080138276 Monoclonal antibody produced by hybridoma with IDAC accession number 180706-02; competitive binding of monoclonal antibody, humanized-, chimeric- or cancerous disease modifying antibodies (CDMAB) with tissue sample induces cytotoxicity; anticarcinogenic, antitumor, and antimetastasis agents; diagnosis |
| 06/12/2008 | US20080138275 Hybridoma cell line G250 and its use for producing monoclonal antibodies |
| 06/12/2008 | CA2699837A1 Variant target binding agents and uses thereof |
| 06/12/2008 | CA2671788A1 Chelating agent |
| 06/12/2008 | CA2671782A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/12/2008 | CA2671632A1 Novel protein kinase modulators and therapeutic uses thereof |
| 06/12/2008 | CA2671311A1 Sulfamatobenzothiophene derivatives |
| 06/12/2008 | CA2670741A1 Combination of an hdac inhibitor and an antimetabolite |
| 06/12/2008 | CA2670375A1 Substituted pyrimidines and their use as jnk modulators |
| 06/12/2008 | CA2670001A1 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 06/12/2008 | CA2664940A1 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 06/11/2008 | EP1930728A1 Use of the mal protein as a tumour marker |
| 06/11/2008 | EP1930433A1 T-cell receptor and nucleic acid encoding the receptor |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930346A1 Antibody produced using ostrich and method for production thereof |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930340A1 Antiproliferative activity of G-rich oligonucleotides and method of using the same to bind to nucleolin |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1930023A2 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930017A1 Composition effective for prevention and treatment of adult disease |
| 06/11/2008 | EP1930001A1 Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 06/11/2008 | EP1929034A1 Cancerous disease modifying antibodies |
| 06/11/2008 | EP1929033A1 Cancerous disease modifying antibodies |
| 06/11/2008 | EP1929013A2 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 06/11/2008 | EP1928880A1 Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 06/11/2008 | EP1928877A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 06/11/2008 | EP1928876A1 Purine derivatives having immuno-modulating properties |
| 06/11/2008 | EP1928875A1 2-amino-7,8-dihydro-6h-pyridoý4,3-d¨pyrimidin-5-ones |
| 06/11/2008 | EP1928872A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
| 06/11/2008 | EP1928861A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |